Kyungok-go for fatigue in long COVID patients: double-blind, randomized, a multi-center, pilot clinical study
- Conditions
- Codes for special purposes
- Registration Number
- KCT0008789
- Lead Sponsor
- Korea Institute of Oriental Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 100
Those aged >19 years who have been diagnosed with COVID-19 for at least 12 weeks.
-Those who has continuously experienced fatigue for >4 weeks that they did not experience before being diagnosed with COVID-19.
-Those who scored >4 points on Fatigue Severity Scale (FSS) score.
-Participants do not have any problems with overall cognitive function and voluntarily agreed to participate in the study through written consent
-Those aged >19 years who have been diagnosed with COVID-19 for at least 12 weeks.
-Those who has continuously experienced fatigue for >4 weeks that they did not experience before being diagnosed with COVID-19.
-Those who scored >4 points on Fatigue Severity Scale (FSS) score.
-Participants do not have any problems with overall cognitive function and voluntarily agreed to participate in the study through written consent
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue Severity Scale (FSS) scores after herbal medicine administration for up to 12 weeks.
- Secondary Outcome Measures
Name Time Method Final medication adherence;Differences in final medication adherence by herbal medicine administration group;Fatigue Severity Scale (FSS) score;ChFS(Chalder Fatigue Scale) score and subscale score;EQ-5D-5L score;K-MOCA(Korean-Montreal cognitive assessment) score;BDI (Becks’ depression inventory) score;DF(digit forward) score, DB(digit backward) score, DF-DB score;Computerized neurocognitive function test score;Short Physical Performance Battery (SPPB);Analysis of target recruitment rate, dropout rate, and dropout reason for feasibility evaluation;Final treatment success rate;PSQI-K (Korean version of Pittsburgh Sleep Quality Index) Global score